Keyphrases
Risk Factors
100%
Baltimore
100%
Seroconversion
100%
Maryland
100%
Virus Type
100%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
100%
Injecting Drug Users
100%
Confidence Interval
50%
Odds Ratio
50%
Enzyme-linked Immunosorbent Assay (ELISA)
33%
Western Blot
33%
Incidence Rate
16%
Risk Analysis
16%
Lag Time
16%
Calendar Time
16%
Seroconverter
16%
Sex Odds
16%
Venipuncture
16%
Sex Partners
16%
Nested Case-control Design
16%
Sharing Practices
16%
Sexual Transmission
16%
Person-time
16%
Needle Sharing
16%
Injection Equipment Sharing
16%
HTLV-II
16%
Backloading
16%
Medicine and Dentistry
Seroconversion
100%
Injecting Drug User
100%
Human T-Lymphotropic Virus Type II
100%
Human T Cell Leukemia Virus
83%
Odds Ratio
50%
Western Blot
33%
Enzyme Immunoassay
33%
Design Controls
16%
Factor Analysis
16%
Vein Puncture
16%
Human T-Lymphotropic Virus 2
16%
Nursing and Health Professions
Virus Typing
100%
Injecting Drug User
100%
Odds Ratio
50%
Confidence Interval
50%
Western Blotting
33%
Enzyme Immunoassay
33%
Factor Analysis
16%
Design Controls
16%
Vein Puncture
16%
Earth and Planetary Sciences
United States of America
100%
Confidence Interval
100%
Maryland
100%
Factor Analysis
33%
Biochemistry, Genetics and Molecular Biology
Seroconversion
100%
Human T Cell Leukemia Virus
83%
Enzyme
33%
Immunoassay
33%
Western Blot
33%
Factor Analysis
16%
Human T-Lymphotropic Virus 2
16%